BS ISO 18310-2:2021 - Measurement and Prediction of Ambient Dose Equivalent

The BS ISO 18310-2:2021 is an essential standard for professionals in the medical and healthcare industry, particularly those involved in nuclear medicine and radiology. This standard provides comprehensive guidelines for the measurement and prediction of the ambient dose equivalent from patients who have undergone iodine 131 administration following thyroid ablation. It also addresses the external effective dose received by caregivers after the patient's release from the hospital.

Released on May 12, 2021, this standard is a critical resource for ensuring the safety and well-being of both patients and caregivers. With a total of 22 pages, it offers detailed methodologies and protocols that are crucial for maintaining compliance with international safety regulations.

Key Features and Benefits

• Comprehensive Guidelines: The standard provides a thorough framework for measuring and predicting radiation doses, ensuring that healthcare providers can accurately assess and manage potential risks.
• Focus on Safety: By addressing the external effective dose to caregivers, the standard emphasizes the importance of protecting those who are in close contact with patients post-treatment.
• International Compliance: As an ISO standard, it aligns with global safety and quality benchmarks, making it a reliable reference for healthcare facilities worldwide.
• Up-to-date Information: Published in 2021, it incorporates the latest research and technological advancements in the field of nuclear medicine.

Who Should Use This Standard?

The BS ISO 18310-2:2021 is indispensable for a wide range of professionals, including:

• Nuclear Medicine Specialists: To ensure accurate dose measurement and prediction for patients undergoing iodine 131 therapy.
• Radiologists: For understanding and implementing safety protocols related to radiation exposure.
• Healthcare Administrators: To develop and enforce policies that protect both patients and staff from unnecessary radiation exposure.
• Regulatory Bodies: For assessing compliance with international safety standards in healthcare facilities.

Technical Details

Standard Number: BS ISO 18310-2:2021
ISBN: 978 0 580 99023 6
Status: Standard

Why Choose BS ISO 18310-2:2021?

Choosing the BS ISO 18310-2:2021 standard means prioritizing the safety and health of both patients and caregivers. It provides a scientifically-backed approach to managing radiation exposure, which is crucial in today's healthcare environment where the use of radioactive substances is prevalent. By adhering to this standard, healthcare providers can ensure they are following best practices and maintaining the highest levels of safety and care.

Furthermore, the standard's focus on the external effective dose to caregivers highlights the importance of considering all aspects of radiation safety, not just the immediate effects on patients. This holistic approach is vital for creating a safe and secure environment in healthcare settings.

Conclusion

The BS ISO 18310-2:2021 is more than just a standard; it is a commitment to excellence in healthcare safety. By implementing its guidelines, healthcare providers can enhance their radiation safety protocols, protect their staff and patients, and ensure compliance with international standards. This standard is a valuable asset for any healthcare facility dedicated to providing the highest quality of care while minimizing risks associated with radiation exposure.

BS ISO 18310-2:2021

This standard BS ISO 18310-2:2021 Measurement and prediction of the ambient dose equivalent from patients receiving iodine 131 administration after thyroid ablation is classified in these ICS categories:

• 13.280 Radiation protection

This document addresses the measurement methods, procedures and uncertainty estimation for the measurement, using a personal dosimeter, of the effective dose to the caregiver in the vicinity of the patient treated with radioiodine to ablate the thyroid.

The general requirements for the patient and caregiver and a guidance (see Annex A) for designated expert on instructing caregivers of discharged patients is considered to effectively measure the effective dose to the caregiver in the vicinity of the patient.